≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Certolizumab pegol

PheWeb

RX_L04AB05

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L04AB05

400

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

319

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

319

diagram downward connector

Include endpoints None

319

diagram downward connector
RX_L04AB05

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 319 243 76
Unadjusted prevalence (%) 0.09 0.12 0.05
Mean age at first event (years) 47.15 46.14 50.38

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L04AB05 – Certolizumab pegol
GWS hits:

Survival analyses between endpoints

↥

Plot

before Certolizumab pegol
after Certolizumab pegol

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Certolizumab pegol

↥